nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—pancreatic cancer—pancreatitis	0.49	1	CtDrD
Doxorubicin—XDH—pancreatitis	0.318	1	CbGaD
Doxorubicin—ABCB11—bile duct—pancreatitis	0.00576	0.1	CbGeAlD
Doxorubicin—ABCB11—bile—pancreatitis	0.00443	0.0769	CbGeAlD
Doxorubicin—ABCC3—bile duct—pancreatitis	0.00367	0.0637	CbGeAlD
Doxorubicin—ABCC2—bile duct—pancreatitis	0.00293	0.0509	CbGeAlD
Doxorubicin—ABCC2—bile—pancreatitis	0.00225	0.0391	CbGeAlD
Doxorubicin—Rash papular—Hyoscyamine—pancreatitis	0.00184	0.0304	CcSEcCtD
Doxorubicin—Supraventricular extrasystoles—Hyoscyamine—pancreatitis	0.00184	0.0304	CcSEcCtD
Doxorubicin—Dermatitis atopic—Propantheline—pancreatitis	0.00181	0.0299	CcSEcCtD
Doxorubicin—Retrosternal pain—Hyoscyamine—pancreatitis	0.0017	0.0282	CcSEcCtD
Doxorubicin—Sinus tachycardia—Hyoscyamine—pancreatitis	0.0017	0.0282	CcSEcCtD
Doxorubicin—Daunorubicin—XDH—pancreatitis	0.00146	1	CrCbGaD
Doxorubicin—AKR1A1—islet of Langerhans—pancreatitis	0.0013	0.0226	CbGeAlD
Doxorubicin—Salivary hypersecretion—Propantheline—pancreatitis	0.0013	0.0215	CcSEcCtD
Doxorubicin—SLC22A16—blood—pancreatitis	0.00129	0.0224	CbGeAlD
Doxorubicin—Blindness—Hyoscyamine—pancreatitis	0.00124	0.0205	CcSEcCtD
Doxorubicin—NDUFS7—islet of Langerhans—pancreatitis	0.00118	0.0206	CbGeAlD
Doxorubicin—Keratitis—Hyoscyamine—pancreatitis	0.00106	0.0175	CcSEcCtD
Doxorubicin—ABCB8—blood—pancreatitis	0.001	0.0174	CbGeAlD
Doxorubicin—Paralysis—Hyoscyamine—pancreatitis	0.000988	0.0163	CcSEcCtD
Doxorubicin—NDUFS2—islet of Langerhans—pancreatitis	0.000982	0.0171	CbGeAlD
Doxorubicin—NDUFS3—islet of Langerhans—pancreatitis	0.00097	0.0168	CbGeAlD
Doxorubicin—CBR3—blood—pancreatitis	0.000966	0.0168	CbGeAlD
Doxorubicin—Laryngitis—Hyoscyamine—pancreatitis	0.000952	0.0157	CcSEcCtD
Doxorubicin—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.000927	0.0153	CcSEcCtD
Doxorubicin—DHCR7—islet of Langerhans—pancreatitis	0.000921	0.016	CbGeAlD
Doxorubicin—AKR1A1—pancreas—pancreatitis	0.000916	0.0159	CbGeAlD
Doxorubicin—Rash erythematous—Hyoscyamine—pancreatitis	0.000896	0.0148	CcSEcCtD
Doxorubicin—Feeling hot—Hyoscyamine—pancreatitis	0.000874	0.0145	CcSEcCtD
Doxorubicin—NQO1—gall bladder—pancreatitis	0.000871	0.0151	CbGeAlD
Doxorubicin—Ageusia—Hyoscyamine—pancreatitis	0.000847	0.014	CcSEcCtD
Doxorubicin—Stinging—Hyoscyamine—pancreatitis	0.000847	0.014	CcSEcCtD
Doxorubicin—Abdominal distension—Propantheline—pancreatitis	0.000846	0.014	CcSEcCtD
Doxorubicin—YWHAG—islet of Langerhans—pancreatitis	0.000845	0.0147	CbGeAlD
Doxorubicin—Dysphagia—Propantheline—pancreatitis	0.000841	0.0139	CcSEcCtD
Doxorubicin—Petechiae—Hyoscyamine—pancreatitis	0.000834	0.0138	CcSEcCtD
Doxorubicin—Blood disorder—Hyoscyamine—pancreatitis	0.000821	0.0136	CcSEcCtD
Doxorubicin—Delirium—Hyoscyamine—pancreatitis	0.000798	0.0132	CcSEcCtD
Doxorubicin—AKR1A1—digestive system—pancreatitis	0.000783	0.0136	CbGeAlD
Doxorubicin—ABCC3—gall bladder—pancreatitis	0.000782	0.0136	CbGeAlD
Doxorubicin—RALBP1—islet of Langerhans—pancreatitis	0.000763	0.0133	CbGeAlD
Doxorubicin—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.00076	0.0126	CcSEcCtD
Doxorubicin—Drowsiness—Propantheline—pancreatitis	0.00075	0.0124	CcSEcCtD
Doxorubicin—AKR1A1—blood—pancreatitis	0.000746	0.0129	CbGeAlD
Doxorubicin—Dysarthria—Hyoscyamine—pancreatitis	0.000725	0.012	CcSEcCtD
Doxorubicin—CBR1—islet of Langerhans—pancreatitis	0.000713	0.0124	CbGeAlD
Doxorubicin—NDUFS7—digestive system—pancreatitis	0.000711	0.0124	CbGeAlD
Doxorubicin—AKR1C3—islet of Langerhans—pancreatitis	0.000704	0.0122	CbGeAlD
Doxorubicin—NDUFS2—pancreas—pancreatitis	0.00069	0.012	CbGeAlD
Doxorubicin—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.000686	0.0113	CcSEcCtD
Doxorubicin—Injection site reaction—Hyoscyamine—pancreatitis	0.000682	0.0113	CcSEcCtD
Doxorubicin—NDUFS3—pancreas—pancreatitis	0.000682	0.0118	CbGeAlD
Doxorubicin—Dermatitis contact—Hyoscyamine—pancreatitis	0.000678	0.0112	CcSEcCtD
Doxorubicin—NDUFS7—blood—pancreatitis	0.000678	0.0118	CbGeAlD
Doxorubicin—AURKA—digestive system—pancreatitis	0.000661	0.0115	CbGeAlD
Doxorubicin—Skin exfoliation—Hyoscyamine—pancreatitis	0.000655	0.0108	CcSEcCtD
Doxorubicin—Blood urea increased—Hyoscyamine—pancreatitis	0.000648	0.0107	CcSEcCtD
Doxorubicin—DHCR7—pancreas—pancreatitis	0.000648	0.0112	CbGeAlD
Doxorubicin—POR—islet of Langerhans—pancreatitis	0.000643	0.0112	CbGeAlD
Doxorubicin—Dry eye—Hyoscyamine—pancreatitis	0.000634	0.0105	CcSEcCtD
Doxorubicin—AURKA—blood—pancreatitis	0.00063	0.0109	CbGeAlD
Doxorubicin—Coma—Hyoscyamine—pancreatitis	0.000627	0.0104	CcSEcCtD
Doxorubicin—Flushing—Propantheline—pancreatitis	0.000625	0.0103	CcSEcCtD
Doxorubicin—Rash maculo-papular—Hyoscyamine—pancreatitis	0.000624	0.0103	CcSEcCtD
Doxorubicin—Pulmonary oedema—Hyoscyamine—pancreatitis	0.000611	0.0101	CcSEcCtD
Doxorubicin—Hypertonia—Hyoscyamine—pancreatitis	0.000601	0.00994	CcSEcCtD
Doxorubicin—YWHAG—pancreas—pancreatitis	0.000594	0.0103	CbGeAlD
Doxorubicin—NOS1—digestive system—pancreatitis	0.000593	0.0103	CbGeAlD
Doxorubicin—NDUFS2—digestive system—pancreatitis	0.000589	0.0102	CbGeAlD
Doxorubicin—NDUFS3—digestive system—pancreatitis	0.000582	0.0101	CbGeAlD
Doxorubicin—Tension—Propantheline—pancreatitis	0.000575	0.0095	CcSEcCtD
Doxorubicin—NQO1—islet of Langerhans—pancreatitis	0.000571	0.00992	CbGeAlD
Doxorubicin—Nervousness—Propantheline—pancreatitis	0.000569	0.00941	CcSEcCtD
Doxorubicin—NOS1—blood—pancreatitis	0.000565	0.00981	CbGeAlD
Doxorubicin—NDUFS2—blood—pancreatitis	0.000561	0.00975	CbGeAlD
Doxorubicin—NDUFS3—blood—pancreatitis	0.000555	0.00963	CbGeAlD
Doxorubicin—Eczema—Hyoscyamine—pancreatitis	0.000554	0.00916	CcSEcCtD
Doxorubicin—DHCR7—digestive system—pancreatitis	0.000553	0.00961	CbGeAlD
Doxorubicin—Vision blurred—Propantheline—pancreatitis	0.000552	0.00913	CcSEcCtD
Doxorubicin—Eye pain—Hyoscyamine—pancreatitis	0.000552	0.00912	CcSEcCtD
Doxorubicin—RALBP1—pancreas—pancreatitis	0.000537	0.00932	CbGeAlD
Doxorubicin—DHCR7—blood—pancreatitis	0.000527	0.00915	CbGeAlD
Doxorubicin—Palpitations—Propantheline—pancreatitis	0.000518	0.00856	CcSEcCtD
Doxorubicin—ABCC6—blood—pancreatitis	0.000514	0.00892	CbGeAlD
Doxorubicin—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00051	0.00844	CcSEcCtD
Doxorubicin—Lethargy—Hyoscyamine—pancreatitis	0.000508	0.0084	CcSEcCtD
Doxorubicin—YWHAG—digestive system—pancreatitis	0.000508	0.00882	CbGeAlD
Doxorubicin—Hyponatraemia—Hyoscyamine—pancreatitis	0.0005	0.00827	CcSEcCtD
Doxorubicin—Osteoarthritis—Hyoscyamine—pancreatitis	0.000498	0.00823	CcSEcCtD
Doxorubicin—XDH—digestive system—pancreatitis	0.000495	0.0086	CbGeAlD
Doxorubicin—AKR1C3—pancreas—pancreatitis	0.000495	0.00859	CbGeAlD
Doxorubicin—Dry mouth—Propantheline—pancreatitis	0.000488	0.00806	CcSEcCtD
Doxorubicin—YWHAG—blood—pancreatitis	0.000483	0.0084	CbGeAlD
Doxorubicin—ABCB11—digestive system—pancreatitis	0.000483	0.0084	CbGeAlD
Doxorubicin—Confusional state—Propantheline—pancreatitis	0.000482	0.00797	CcSEcCtD
Doxorubicin—Anaphylactic shock—Propantheline—pancreatitis	0.000478	0.0079	CcSEcCtD
Doxorubicin—Cardiac arrest—Hyoscyamine—pancreatitis	0.000474	0.00783	CcSEcCtD
Doxorubicin—Ataxia—Hyoscyamine—pancreatitis	0.000468	0.00774	CcSEcCtD
Doxorubicin—Tachycardia—Propantheline—pancreatitis	0.000467	0.00771	CcSEcCtD
Doxorubicin—Dehydration—Hyoscyamine—pancreatitis	0.000463	0.00766	CcSEcCtD
Doxorubicin—RALBP1—digestive system—pancreatitis	0.000458	0.00796	CbGeAlD
Doxorubicin—Dry skin—Hyoscyamine—pancreatitis	0.000456	0.00755	CcSEcCtD
Doxorubicin—Hypokalaemia—Hyoscyamine—pancreatitis	0.000453	0.00749	CcSEcCtD
Doxorubicin—NOS3—digestive system—pancreatitis	0.000451	0.00783	CbGeAlD
Doxorubicin—RALBP1—blood—pancreatitis	0.000437	0.00758	CbGeAlD
Doxorubicin—Abdominal distension—Hyoscyamine—pancreatitis	0.000433	0.00716	CcSEcCtD
Doxorubicin—Insomnia—Propantheline—pancreatitis	0.000432	0.00715	CcSEcCtD
Doxorubicin—Dysphagia—Hyoscyamine—pancreatitis	0.00043	0.00712	CcSEcCtD
Doxorubicin—NOS3—blood—pancreatitis	0.00043	0.00746	CbGeAlD
Doxorubicin—CBR1—digestive system—pancreatitis	0.000428	0.00743	CbGeAlD
Doxorubicin—Somnolence—Propantheline—pancreatitis	0.000425	0.00703	CcSEcCtD
Doxorubicin—Angina pectoris—Hyoscyamine—pancreatitis	0.000419	0.00693	CcSEcCtD
Doxorubicin—Constipation—Propantheline—pancreatitis	0.000409	0.00676	CcSEcCtD
Doxorubicin—CBR1—blood—pancreatitis	0.000408	0.00708	CbGeAlD
Doxorubicin—AKR1C3—blood—pancreatitis	0.000403	0.00699	CbGeAlD
Doxorubicin—Dysuria—Hyoscyamine—pancreatitis	0.000402	0.00665	CcSEcCtD
Doxorubicin—NQO1—pancreas—pancreatitis	0.000401	0.00697	CbGeAlD
Doxorubicin—Feeling abnormal—Propantheline—pancreatitis	0.000394	0.00651	CcSEcCtD
Doxorubicin—Hyperglycaemia—Hyoscyamine—pancreatitis	0.000388	0.00642	CcSEcCtD
Doxorubicin—Drowsiness—Hyoscyamine—pancreatitis	0.000384	0.00634	CcSEcCtD
Doxorubicin—Urticaria—Propantheline—pancreatitis	0.00038	0.00628	CcSEcCtD
Doxorubicin—Conjunctivitis—Hyoscyamine—pancreatitis	0.000373	0.00617	CcSEcCtD
Doxorubicin—Sweating—Hyoscyamine—pancreatitis	0.000368	0.00608	CcSEcCtD
Doxorubicin—POR—blood—pancreatitis	0.000368	0.00639	CbGeAlD
Doxorubicin—Hypersensitivity—Propantheline—pancreatitis	0.000352	0.00582	CcSEcCtD
Doxorubicin—Bradycardia—Hyoscyamine—pancreatitis	0.000351	0.0058	CcSEcCtD
Doxorubicin—Asthenia—Propantheline—pancreatitis	0.000343	0.00567	CcSEcCtD
Doxorubicin—NQO1—digestive system—pancreatitis	0.000343	0.00595	CbGeAlD
Doxorubicin—TOP2A—blood—pancreatitis	0.000343	0.00595	CbGeAlD
Doxorubicin—Flushing—Hyoscyamine—pancreatitis	0.00032	0.00529	CcSEcCtD
Doxorubicin—Dizziness—Propantheline—pancreatitis	0.000316	0.00523	CcSEcCtD
Doxorubicin—Arrhythmia—Hyoscyamine—pancreatitis	0.000308	0.00509	CcSEcCtD
Doxorubicin—ABCC3—digestive system—pancreatitis	0.000308	0.00534	CbGeAlD
Doxorubicin—ABCC10—digestive system—pancreatitis	0.000306	0.00532	CbGeAlD
Doxorubicin—Vomiting—Propantheline—pancreatitis	0.000304	0.00503	CcSEcCtD
Doxorubicin—Mental disorder—Hyoscyamine—pancreatitis	0.000302	0.00499	CcSEcCtD
Doxorubicin—Rash—Propantheline—pancreatitis	0.000301	0.00498	CcSEcCtD
Doxorubicin—Dermatitis—Propantheline—pancreatitis	0.000301	0.00498	CcSEcCtD
Doxorubicin—Erythema—Hyoscyamine—pancreatitis	0.0003	0.00496	CcSEcCtD
Doxorubicin—Headache—Propantheline—pancreatitis	0.0003	0.00495	CcSEcCtD
Doxorubicin—Tension—Hyoscyamine—pancreatitis	0.000294	0.00487	CcSEcCtD
Doxorubicin—Dysgeusia—Hyoscyamine—pancreatitis	0.000294	0.00486	CcSEcCtD
Doxorubicin—ABCC3—blood—pancreatitis	0.000293	0.00509	CbGeAlD
Doxorubicin—ABCC10—blood—pancreatitis	0.000292	0.00507	CbGeAlD
Doxorubicin—Nervousness—Hyoscyamine—pancreatitis	0.000291	0.00482	CcSEcCtD
Doxorubicin—Nausea—Propantheline—pancreatitis	0.000284	0.0047	CcSEcCtD
Doxorubicin—Vision blurred—Hyoscyamine—pancreatitis	0.000283	0.00467	CcSEcCtD
Doxorubicin—Agitation—Hyoscyamine—pancreatitis	0.000276	0.00456	CcSEcCtD
Doxorubicin—Vertigo—Hyoscyamine—pancreatitis	0.000269	0.00445	CcSEcCtD
Doxorubicin—Syncope—Hyoscyamine—pancreatitis	0.000269	0.00445	CcSEcCtD
Doxorubicin—Palpitations—Hyoscyamine—pancreatitis	0.000265	0.00438	CcSEcCtD
Doxorubicin—Loss of consciousness—Hyoscyamine—pancreatitis	0.000264	0.00436	CcSEcCtD
Doxorubicin—Convulsion—Hyoscyamine—pancreatitis	0.00026	0.0043	CcSEcCtD
Doxorubicin—Chest pain—Hyoscyamine—pancreatitis	0.000255	0.00422	CcSEcCtD
Doxorubicin—Anxiety—Hyoscyamine—pancreatitis	0.000254	0.00421	CcSEcCtD
Doxorubicin—Dry mouth—Hyoscyamine—pancreatitis	0.00025	0.00413	CcSEcCtD
Doxorubicin—Confusional state—Hyoscyamine—pancreatitis	0.000247	0.00408	CcSEcCtD
Doxorubicin—ABCC2—digestive system—pancreatitis	0.000246	0.00427	CbGeAlD
Doxorubicin—Anaphylactic shock—Hyoscyamine—pancreatitis	0.000245	0.00405	CcSEcCtD
Doxorubicin—Oedema—Hyoscyamine—pancreatitis	0.000245	0.00405	CcSEcCtD
Doxorubicin—Shock—Hyoscyamine—pancreatitis	0.000241	0.00398	CcSEcCtD
Doxorubicin—CYP1B1—digestive system—pancreatitis	0.000241	0.00418	CbGeAlD
Doxorubicin—Tachycardia—Hyoscyamine—pancreatitis	0.000239	0.00395	CcSEcCtD
Doxorubicin—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000237	0.00391	CcSEcCtD
Doxorubicin—ABCC2—blood—pancreatitis	0.000234	0.00407	CbGeAlD
Doxorubicin—CYP1B1—blood—pancreatitis	0.000229	0.00398	CbGeAlD
Doxorubicin—Hypotension—Hyoscyamine—pancreatitis	0.000229	0.00378	CcSEcCtD
Doxorubicin—Insomnia—Hyoscyamine—pancreatitis	0.000221	0.00366	CcSEcCtD
Doxorubicin—Dyspnoea—Hyoscyamine—pancreatitis	0.000218	0.00361	CcSEcCtD
Doxorubicin—Somnolence—Hyoscyamine—pancreatitis	0.000218	0.0036	CcSEcCtD
Doxorubicin—Dyspepsia—Hyoscyamine—pancreatitis	0.000215	0.00356	CcSEcCtD
Doxorubicin—Fatigue—Hyoscyamine—pancreatitis	0.000211	0.00349	CcSEcCtD
Doxorubicin—Pain—Hyoscyamine—pancreatitis	0.000209	0.00346	CcSEcCtD
Doxorubicin—Constipation—Hyoscyamine—pancreatitis	0.000209	0.00346	CcSEcCtD
Doxorubicin—ABCC1—blood—pancreatitis	0.000206	0.00358	CbGeAlD
Doxorubicin—Feeling abnormal—Hyoscyamine—pancreatitis	0.000202	0.00333	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.0002	0.00331	CcSEcCtD
Doxorubicin—Urticaria—Hyoscyamine—pancreatitis	0.000194	0.00321	CcSEcCtD
Doxorubicin—Abdominal pain—Hyoscyamine—pancreatitis	0.000193	0.0032	CcSEcCtD
Doxorubicin—Body temperature increased—Hyoscyamine—pancreatitis	0.000193	0.0032	CcSEcCtD
Doxorubicin—Hypersensitivity—Hyoscyamine—pancreatitis	0.00018	0.00298	CcSEcCtD
Doxorubicin—Asthenia—Hyoscyamine—pancreatitis	0.000176	0.0029	CcSEcCtD
Doxorubicin—Pruritus—Hyoscyamine—pancreatitis	0.000173	0.00286	CcSEcCtD
Doxorubicin—ABCG2—blood—pancreatitis	0.000171	0.00297	CbGeAlD
Doxorubicin—Diarrhoea—Hyoscyamine—pancreatitis	0.000167	0.00277	CcSEcCtD
Doxorubicin—CYP2B6—digestive system—pancreatitis	0.000165	0.00287	CbGeAlD
Doxorubicin—Dizziness—Hyoscyamine—pancreatitis	0.000162	0.00268	CcSEcCtD
Doxorubicin—CYP2B6—blood—pancreatitis	0.000158	0.00274	CbGeAlD
Doxorubicin—Vomiting—Hyoscyamine—pancreatitis	0.000156	0.00257	CcSEcCtD
Doxorubicin—Rash—Hyoscyamine—pancreatitis	0.000154	0.00255	CcSEcCtD
Doxorubicin—Dermatitis—Hyoscyamine—pancreatitis	0.000154	0.00255	CcSEcCtD
Doxorubicin—Headache—Hyoscyamine—pancreatitis	0.000153	0.00253	CcSEcCtD
Doxorubicin—ABCB1—islet of Langerhans—pancreatitis	0.000147	0.00256	CbGeAlD
Doxorubicin—Nausea—Hyoscyamine—pancreatitis	0.000145	0.0024	CcSEcCtD
Doxorubicin—CYP3A4—digestive system—pancreatitis	0.000125	0.00217	CbGeAlD
Doxorubicin—CYP2D6—digestive system—pancreatitis	0.000123	0.00213	CbGeAlD
Doxorubicin—CYP3A4—blood—pancreatitis	0.000119	0.00207	CbGeAlD
Doxorubicin—CYP2D6—blood—pancreatitis	0.000117	0.00203	CbGeAlD
Doxorubicin—ABCB1—pancreas—pancreatitis	0.000104	0.0018	CbGeAlD
Doxorubicin—ABCB1—digestive system—pancreatitis	8.84e-05	0.00154	CbGeAlD
Doxorubicin—ABCB1—blood—pancreatitis	8.42e-05	0.00146	CbGeAlD
Doxorubicin—NOS3—Metabolism—GCG—pancreatitis	1.1e-05	0.000152	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GCG—pancreatitis	1.09e-05	0.00015	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL2—pancreatitis	1.09e-05	0.00015	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADH4—pancreatitis	1.09e-05	0.00015	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PPP3CA—pancreatitis	1.08e-05	0.000148	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—LPL—pancreatitis	1.06e-05	0.000146	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—pancreatitis	1.06e-05	0.000146	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGA—pancreatitis	1.06e-05	0.000146	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—KRAS—pancreatitis	1.06e-05	0.000145	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MDM2—pancreatitis	1.05e-05	0.000145	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MDM2—pancreatitis	1.05e-05	0.000145	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KNG1—pancreatitis	1.05e-05	0.000144	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—pancreatitis	1.04e-05	0.000144	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.03e-05	0.000142	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SST—pancreatitis	1.03e-05	0.000142	CbGpPWpGaD
Doxorubicin—NOS3—Disease—LPL—pancreatitis	1.03e-05	0.000142	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DUSP6—pancreatitis	1.02e-05	0.000141	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—LPL—pancreatitis	1.02e-05	0.000141	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PRSS1—pancreatitis	1.02e-05	0.000141	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—pancreatitis	1.01e-05	0.000139	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PLA2G1B—pancreatitis	1e-05	0.000138	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CTRB2—pancreatitis	9.95e-06	0.000137	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—pancreatitis	9.91e-06	0.000136	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BDKRB2—pancreatitis	9.71e-06	0.000134	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PLA2G1B—pancreatitis	9.69e-06	0.000133	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PNLIP—pancreatitis	9.69e-06	0.000133	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PRSS3—pancreatitis	9.69e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—A2M—pancreatitis	9.68e-06	0.000133	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PDGFA—pancreatitis	9.62e-06	0.000132	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CNR1—pancreatitis	9.53e-06	0.000131	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NRAS—pancreatitis	9.52e-06	0.000131	CbGpPWpGaD
Doxorubicin—NOS2—Disease—INS—pancreatitis	9.52e-06	0.000131	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—LPL—pancreatitis	9.51e-06	0.000131	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—pancreatitis	9.42e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PPP3CA—pancreatitis	9.38e-06	0.000129	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CTRB2—pancreatitis	9.37e-06	0.000129	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—A2M—pancreatitis	9.36e-06	0.000129	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GCG—pancreatitis	9.21e-06	0.000127	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MDM2—pancreatitis	9.19e-06	0.000127	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	9.04e-06	0.000124	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—pancreatitis	8.97e-06	0.000124	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GCG—pancreatitis	8.93e-06	0.000123	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALDH2—pancreatitis	8.85e-06	0.000122	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—pancreatitis	8.85e-06	0.000122	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KNG1—pancreatitis	8.84e-06	0.000122	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLA2G1B—pancreatitis	8.82e-06	0.000121	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL5—pancreatitis	8.74e-06	0.00012	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—INS—pancreatitis	8.74e-06	0.00012	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—XDH—pancreatitis	8.69e-06	0.00012	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	8.67e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—LPL—pancreatitis	8.64e-06	0.000119	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	8.63e-06	0.000119	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—FDX1—pancreatitis	8.62e-06	0.000119	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL8—pancreatitis	8.6e-06	0.000118	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GCG—pancreatitis	8.56e-06	0.000118	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALDH2—pancreatitis	8.56e-06	0.000118	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LPL—pancreatitis	8.55e-06	0.000118	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—A2M—pancreatitis	8.52e-06	0.000117	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	8.35e-06	0.000115	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CASP3—pancreatitis	8.23e-06	0.000113	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—KRAS—pancreatitis	8.2e-06	0.000113	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—FDX1—pancreatitis	8.13e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PDGFA—pancreatitis	8.13e-06	0.000112	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADH1B—pancreatitis	8.11e-06	0.000112	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—pancreatitis	8.1e-06	0.000112	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	8.02e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADH4—pancreatitis	8.02e-06	0.00011	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MDM2—pancreatitis	7.92e-06	0.000109	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NRAS—pancreatitis	7.87e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALDH2—pancreatitis	7.79e-06	0.000107	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	7.76e-06	0.000107	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PPARG—pancreatitis	7.74e-06	0.000107	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	7.74e-06	0.000107	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2A—pancreatitis	7.71e-06	0.000106	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—pancreatitis	7.63e-06	0.000105	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—INS—pancreatitis	7.59e-06	0.000105	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADH4—pancreatitis	7.56e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PRSS1—pancreatitis	7.54e-06	0.000104	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	7.51e-06	0.000103	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—pancreatitis	7.47e-06	0.000103	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PPARG—pancreatitis	7.47e-06	0.000103	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL5—pancreatitis	7.39e-06	0.000102	CbGpPWpGaD
Doxorubicin—NOS3—Disease—INS—pancreatitis	7.39e-06	0.000102	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—pancreatitis	7.38e-06	0.000102	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—INS—pancreatitis	7.32e-06	0.000101	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—pancreatitis	7.32e-06	0.000101	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MDM2—pancreatitis	7.27e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LPL—pancreatitis	7.22e-06	9.95e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	7.18e-06	9.89e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LEP—pancreatitis	7.17e-06	9.87e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PNLIP—pancreatitis	7.15e-06	9.84e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PRSS3—pancreatitis	7.15e-06	9.84e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PRSS1—pancreatitis	7.1e-06	9.78e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PDGFA—pancreatitis	7.07e-06	9.74e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—pancreatitis	7.01e-06	9.66e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—LPL—pancreatitis	7.01e-06	9.65e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—pancreatitis	6.97e-06	9.59e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—pancreatitis	6.96e-06	9.58e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PPARG—pancreatitis	6.94e-06	9.56e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NRAS—pancreatitis	6.9e-06	9.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—pancreatitis	6.84e-06	9.42e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—INS—pancreatitis	6.81e-06	9.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	6.79e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KRAS—pancreatitis	6.78e-06	9.33e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PRSS3—pancreatitis	6.73e-06	9.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PNLIP—pancreatitis	6.73e-06	9.27e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—LPL—pancreatitis	6.72e-06	9.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—pancreatitis	6.71e-06	9.24e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GCG—pancreatitis	6.71e-06	9.24e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	6.57e-06	9.04e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—pancreatitis	6.51e-06	8.97e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—pancreatitis	6.49e-06	8.94e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GCG—pancreatitis	6.49e-06	8.94e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLA2G1B—pancreatitis	6.47e-06	8.9e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—XDH—pancreatitis	6.41e-06	8.83e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—pancreatitis	6.41e-06	8.82e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARG—pancreatitis	6.31e-06	8.69e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—LPL—pancreatitis	6.29e-06	8.66e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—A2M—pancreatitis	6.24e-06	8.6e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—pancreatitis	6.24e-06	8.59e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—INS—pancreatitis	6.19e-06	8.52e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MDM2—pancreatitis	6.15e-06	8.46e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CTRB2—pancreatitis	6.13e-06	8.44e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—INS—pancreatitis	6.12e-06	8.43e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—pancreatitis	6.09e-06	8.38e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LEP—pancreatitis	6.06e-06	8.34e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—XDH—pancreatitis	6.04e-06	8.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—pancreatitis	6.02e-06	8.3e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADH1B—pancreatitis	5.98e-06	8.23e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NRAS—pancreatitis	5.94e-06	8.18e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KRAS—pancreatitis	5.94e-06	8.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—pancreatitis	5.93e-06	8.16e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GCG—pancreatitis	5.9e-06	8.13e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—pancreatitis	5.87e-06	8.09e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—pancreatitis	5.76e-06	7.93e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALDH2—pancreatitis	5.71e-06	7.86e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—pancreatitis	5.67e-06	7.81e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADH1B—pancreatitis	5.63e-06	7.76e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	5.59e-06	7.7e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—pancreatitis	5.52e-06	7.6e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—pancreatitis	5.51e-06	7.59e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—pancreatitis	5.46e-06	7.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRAS—pancreatitis	5.46e-06	7.51e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FDX1—pancreatitis	5.31e-06	7.32e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LPL—pancreatitis	5.27e-06	7.25e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	5.22e-06	7.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	5.18e-06	7.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—INS—pancreatitis	5.17e-06	7.12e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—pancreatitis	5.12e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—pancreatitis	5.11e-06	7.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MDM2—pancreatitis	5.09e-06	7.01e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LPL—pancreatitis	5.09e-06	7.01e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—pancreatitis	5.09e-06	7.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—pancreatitis	5.07e-06	6.98e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—pancreatitis	5.04e-06	6.95e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—INS—pancreatitis	5.02e-06	6.91e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—pancreatitis	4.96e-06	6.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADH4—pancreatitis	4.94e-06	6.8e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—pancreatitis	4.91e-06	6.76e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—pancreatitis	4.83e-06	6.65e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—INS—pancreatitis	4.81e-06	6.63e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLA2G1B—pancreatitis	4.77e-06	6.57e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—pancreatitis	4.76e-06	6.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—pancreatitis	4.7e-06	6.47e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PRSS1—pancreatitis	4.64e-06	6.4e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LPL—pancreatitis	4.63e-06	6.38e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRAS—pancreatitis	4.61e-06	6.35e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—A2M—pancreatitis	4.61e-06	6.34e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—pancreatitis	4.6e-06	6.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—pancreatitis	4.56e-06	6.28e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—INS—pancreatitis	4.5e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLA2G1B—pancreatitis	4.49e-06	6.19e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—pancreatitis	4.41e-06	6.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PNLIP—pancreatitis	4.4e-06	6.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PRSS3—pancreatitis	4.4e-06	6.06e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—pancreatitis	4.34e-06	5.98e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—A2M—pancreatitis	4.34e-06	5.98e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GCG—pancreatitis	4.33e-06	5.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MDM2—pancreatitis	4.3e-06	5.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—pancreatitis	4.28e-06	5.9e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALDH2—pancreatitis	4.21e-06	5.8e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—pancreatitis	4.16e-06	5.73e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—pancreatitis	4.03e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—pancreatitis	4.02e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—pancreatitis	3.99e-06	5.5e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALDH2—pancreatitis	3.97e-06	5.47e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—pancreatitis	3.97e-06	5.46e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—XDH—pancreatitis	3.95e-06	5.44e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—pancreatitis	3.86e-06	5.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—pancreatitis	3.85e-06	5.3e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—pancreatitis	3.84e-06	5.29e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—pancreatitis	3.82e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—pancreatitis	3.82e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INS—pancreatitis	3.77e-06	5.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MDM2—pancreatitis	3.75e-06	5.16e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—pancreatitis	3.72e-06	5.12e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADH1B—pancreatitis	3.68e-06	5.07e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INS—pancreatitis	3.65e-06	5.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—pancreatitis	3.61e-06	4.97e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—pancreatitis	3.55e-06	4.89e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	3.51e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—pancreatitis	3.46e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LPL—pancreatitis	3.4e-06	4.68e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—pancreatitis	3.38e-06	4.66e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—pancreatitis	3.37e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—pancreatitis	3.34e-06	4.6e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INS—pancreatitis	3.32e-06	4.57e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—pancreatitis	3.29e-06	4.53e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—pancreatitis	3.23e-06	4.45e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—pancreatitis	3.23e-06	4.45e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCG—pancreatitis	3.19e-06	4.4e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—pancreatitis	3.04e-06	4.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—pancreatitis	3.02e-06	4.16e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCG—pancreatitis	3.01e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—pancreatitis	3e-06	4.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G1B—pancreatitis	2.94e-06	4.05e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—pancreatitis	2.92e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—A2M—pancreatitis	2.84e-06	3.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—pancreatitis	2.81e-06	3.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—pancreatitis	2.8e-06	3.85e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—pancreatitis	2.78e-06	3.83e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—pancreatitis	2.68e-06	3.68e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—pancreatitis	2.66e-06	3.66e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—pancreatitis	2.61e-06	3.59e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDH2—pancreatitis	2.6e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPL—pancreatitis	2.5e-06	3.45e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—pancreatitis	2.48e-06	3.41e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INS—pancreatitis	2.43e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—pancreatitis	2.42e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—pancreatitis	2.36e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPL—pancreatitis	2.36e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—pancreatitis	2.26e-06	3.11e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—pancreatitis	2.23e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—pancreatitis	2.06e-06	2.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—pancreatitis	1.97e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCG—pancreatitis	1.97e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—pancreatitis	1.95e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—pancreatitis	1.83e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INS—pancreatitis	1.79e-06	2.47e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—pancreatitis	1.72e-06	2.37e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INS—pancreatitis	1.69e-06	2.33e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—pancreatitis	1.64e-06	2.26e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—pancreatitis	1.55e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPL—pancreatitis	1.54e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—pancreatitis	1.44e-06	1.98e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—pancreatitis	1.36e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—pancreatitis	1.13e-06	1.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INS—pancreatitis	1.11e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—pancreatitis	1.01e-06	1.4e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—pancreatitis	8.86e-07	1.22e-05	CbGpPWpGaD
